Have a personal or library account? Click to login
Patient with Newly Diagnosed HIV Infection in Aids Stage Who Developed Oesophageal Candidiasis and Miliary Tuberculosis: A Case Report Cover

Patient with Newly Diagnosed HIV Infection in Aids Stage Who Developed Oesophageal Candidiasis and Miliary Tuberculosis: A Case Report

Open Access
|Sep 2024

Abstract

This clinical case is about a 50-year old woman, a refugee from Ukraine, without known epidemiological risk factors, with newly diagnosed human immunodeficiency virus-1 (HIV-1) infection in acquired immune deficiency syndrome (AIDS) stage. Qesophageal candidiasis as an indicator disease of HIV in this case was the first diagnosis that promoted further investigation, revealing both primary HIV infection and sequentially other opportunistic infections — cytomegalovirus, Epstein Barr virus, and miliary tuberculosis. Oesophageal candidiasis was visualised by the oesophagogastroduodenoscopy method, which was initially performed due to detected anaemia to rule out bleeding from the gastrointestinal tract. Deep immunosuppression was provided to this patient and this led to the development of miliary tuberculosis, worsening the prognosis. The patient was prescribed treatment for several opportunistic infections, also anti tuberculosis treatment, as well as combined antiretroviral treatment, which stabilised the situation. In this case our patient developed odynophagia and dysphagia, common complications of oesophageal candidiasis, so she had to receive nutrition through a nasogastric tube.

DOI: https://doi.org/10.2478/prolas-2024-0044 | Journal eISSN: 2255-890X | Journal ISSN: 1407-009X
Language: English
Page range: 317 - 322
Submitted on: Mar 1, 2024
Accepted on: Jun 13, 2024
Published on: Sep 5, 2024
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2024 Žanna Jevsjutina, Indra Zeltiņa, Anda Šurpicka, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons Attribution 4.0 License.